Verona Pharma plc

VRNA

Held by 6 specialist biotech funds

High ConvergenceSpecialists adding · Low short pressure

Share on X

Fund Holdings

6 fund convergence

Eventide Asset Management

3 quarters

Position Trend

Aug 14, 2025

$1138.4M

6 funds

Nov 14, 2025

$128.6M

2 funds

Feb 13, 2026

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 6 quarters

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/ARA Capital Management0.7%Aug 14, 2025

SC 13G/ARA Capital Management7.1%May 15, 2025

SC 13G/ARA Capital Management8.9%Feb 14, 2025

SC 13G/ARA Capital Management10.0%Nov 14, 2024

SC 13G/ARA Capital Management10.0%Feb 14, 2024

SC 13G/ARA Capital Management10.0%Feb 14, 2023

SC 13G/ARA Capital Management10.0%Feb 14, 2022

SC 13GRA Capital Management10.0%Feb 16, 2021

Position Details

Perceptive AdvisorsEXITFeb 17, 2026

Shares: 0Value: N/A

Driehaus CapitalEXITFeb 17, 2026

Shares: 0Value: N/A

+ 20more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

BBNX4 funds EWTX3 funds NUVL3 funds CNTA3 funds INSM3 funds KOD3 funds CELC3 funds WVE3 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: